BIOGEN INC. (BIIB) Capital expenditures 2016–2025
BIOGEN INC. (BIIB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$153.8MFY2025 · since FY2016: $616.1M → $153.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $153.8M | +0.1% |
| FY2024 | $153.7M | -44.5% |
| FY2023 | $277.0M | +15.3% |
| FY2022 | $240.3M | -6.9% |
| FY2021 | $258.1M | -39.2% |
| FY2020 | $424.8M | -17.4% |
| FY2019 | $514.5M | -33.2% |
| FY2018 | $770.6M | -11.2% |
| FY2017 | $867.4M | +40.8% |
| FY2016 | $616.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice